Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells.

Leukemia research - 1 Mar 2004

Genty Vincent, Dine Gérard, Dufer Jean

Abstract excerpt

Resistance to glucocorticoids (GCs) frequently appears during treatment of hematological malignancies. This study investigates the phenotypical alterations observed in human myeloma cell sublines resistant to glucocorticoids. Using the RPMI8226 cell line, the cytotoxic efficiencies of four glucocorticoids, and the phenotypes of isolated resistant sublines were analyzed. Methyl-prednisolone and dexamethasone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Dexamethasone
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucocorticoids

Share to Methylprednisolone

Share to Multiple Myeloma

Share to Prednisolone

Share to Prednisone

Source

Identifiers

PMID: 14687627
DOI: 10.1016/j.leukres.2003.08.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells.PMID 14687627Read ↗

Nuclear chromatin patterns in 3 glucocorticoid-resistant RPMI 8226 human myeloma cell sub-lines: correlations with cell growth and immunological phenotype.Semantic proximity Read ↗

Cellular resistance mechanisms with impact on the therapy of multiple myeloma.Semantic proximity Read ↗

Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cellsSemantic proximity Read ↗

Glucocorticoid Receptors and Resistance to Glucocorticoids in Hematologic MalignanciesSemantic proximity Read ↗

A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNASemantic proximity Read ↗

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myelomaSemantic proximity Read ↗

A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA.Semantic proximity Read ↗

Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis.Semantic proximity Read ↗

In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma.Semantic proximity Read ↗

Glucocorticoid Resistance in Childhood LeukemiaSemantic proximity Read ↗

Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.Semantic proximity Read ↗

Extracellular matrix in bone marrow can mediate drug resistance in myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.